NEWS & PRESS RELEASES
SATURN Transapical Early Feasibility in Annals of Thoraric Surgery Short Reports
Annals of Thoracic Surgery Short Reports just published Early Feasibility Study with the SATURN Transapical Mitral Valve Replacement Device, available at https://doi.org/10.1016/j.atssr.2024.06.011. Deep gratitude and congratulation to the authors: Prof. Kęstutis...
Presentation of Saturn and First-in-Human TS at NY Valves – June 2024
Our technology and first trans-septal implant have been presented at NY Valves 2024 held on June 5-7 in Jacob K. Javits Convention Center, New York. Specifically, Dr. Lauren S. Ranard, MD from Columbia University Irving Medical Center, held a presentation named...
First-In-Human Trans-Septal Implantation of Saturn Mitral Valve Replacement
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”
William Pollard